<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
Latest 10 SEDI filings (by transaction date) for RVX within the last 6 months
|
?
|
Amended Filing
|
|
As of 11:59pm ET November 22nd, 2015
|
Filing Date
|
Transaction Date
|
Insider Name
|
Ownership Type
|
Securities
|
Nature of transaction
|
Volume or Value
|
Price
|
Oct 8/15
|
Oct 7/15
|
Zuerblis, Kenneth
|
Direct Ownership
|
Options
|
52 - Expiration of options
|
-150,000
|
|
Aug 6/15
|
Aug 6/15
|
Mccaffrey, Donald J.
|
Direct Ownership
|
Options
|
52 - Expiration of options
|
-100,000
|
|
Jul 24/15
|
Jul 20/15
|
Shenzhen Hepalink Pharmaceutical Co., Ltd.
|
Direct Ownership
|
Warrants
|
53 - Grant of warrants
|
1,000,000
|
|
Jul 24/15
|
Jul 20/15
|
Shenzhen Hepalink Pharmaceutical Co., Ltd.
|
Direct Ownership
|
Common Shares
|
16 - Acquisition under a prospectus exemption
|
13,270,000
|
$2.6
|